Original contributionOverexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer☆
References (50)
- et al.
Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas
Cell
(1982) - et al.
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
Cell
(1988) The evolution of colorectal carcinoma
Clin Radiol
(1984)Cellular and molecular aspects of neoplastic progression in the mammary gland
Eur J Cancer Clin Oncol
(1988)- et al.
In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFR and PDGFR-b-subunit
Mol Cell Probes
(1990) - et al.
Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts
Nature
(1981) - et al.
The c-neu oncogene: An erbB-related gene encoding a 185,000 MW tumour antigen
Nature
(1984) - et al.
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
Science
(1985) - et al.
A v-erb related proto-oncogene, c-erbB-2, is distinct from c-erbB-1/epidermal growth factor receptor gene and is amplified in a human salivary gland adenocarcinoma
- et al.
Amplification of a novel v-erbB-related gene in human mammary carcinoma
Science
(1985)
The c-neu gene: An erbB-homologous gene distinct from and unlinked to genes encoding the EFG receptor
Science
(1985)
Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen
Direct interaction of a ligand for the erbB-2 oncogene produced with the EGF receptor and p185 erbB-2
Science
(1991)
Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
Science
(1987)
Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene
Mol Cell Biol
(1987)
Amplification of c-erbB-2 and aggressive human breast tumors
Science
(1988)
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
Science
(1989)
HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer
Oncogene
(1989)
Proto-oncogene amplification and human breast tumor phenotype
Oncogene
(1989)
Genetic alterations of c-myc, c-erbB-2, and c-Haras protooncogenes and clinical associations in human breast carcinomas
Cancer Res
(1989)
Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: and c-erbB2/ear-1
Cancer Res
(1989)
Proto-oncogene abonormalities in human breast cancer: c-erbB-2 amplification does not correlate with recurrence of disease
Oncogene
(1989)
Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma
Cancer
(1990)
HER-2/neu amplification predicts poor survival in node-positive breast cancer
Cancer Res
(1990)
HER-2/neu oncogene protein and prognosis in breast cancer
J Clin Oncol
(1989)
Cited by (0)
- ☆
This intergroup study (INT 0076, EST 7186, SWOG 8696) was coordinated by the Eastern Cooperative Oncology Group (Chairman, Paul P. Carbone, MD; NCI grants no. CA21115, CA23318, and CA30195). The results were presented at the 1990 annual meeting of the American Society of Clinical Oncology. The late William L. McGuire was a Clinical Research Professor of the American Cancer Society.
- †
Deceased.
Copyright © 1992 Published by Elsevier Inc.